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Abstract:  We discovered that hemoglobin emits high energy Soret 
fluorescence when two-photon excited by the visible femtosecond light 
sources. The unique spectral and temporal characteristics of hemoglobin 
fluorescence were measured by using a time-resolved spectroscopic 
detection system. The high energy Soret fluorescence of hemoglobin shows 
the spectral peak at 438 nm with extremely short lifetime. This discovery 
enables two-photon excitation fluorescence microscopy to become a 
potentially powerful tool for in vivo label-free imaging of blood cells and 
vessels. 
©2010 Optical Society of America 
OCIS codes:  (170.0170) Medical optics and biotechnology; (300.6500) spectroscopy, time-
resolved; (300.6410) Spectroscopy, multiphoton; (170.2520) Fluorescence microscopy; 
(180.4315) Nonlinear microscopy. 
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1. Introduction 
Two-photon excitation fluorescence (TPEF) microscopy has become a mainstream biological 
imaging tool after two decades of development [1–3]. In particular, noninvasive label-free 
imaging capability of TPEF microscopy can be achieved by using the fluorescence emission 
from the endogenous fluorescent molecules in living cells and tissue, such as the reduced 
nicotinamide adenine dinucleotide (NADH), tryptophan, flavin adenine dinucleotide (FAD), 
keratin, collagen and elastin etc. These endogenous fluorescence signals provide rich 
morphologic and biochemical information of the imaged biological samples. However, TPEF 
microscopy has to rely on exogenous fluorescent agents for three dimensional (3-D) 
volumetric visualization of the delicate features of microvasculature and the contrast agents 
could induce disturbance to the biological processes in the living cells and tissue [4]. The 
difficulties for label-free visualizing of blood is associated with the widely spread hypothesis 
that hemoglobin has undetectable fluorescence due to  that its spontaneous emission is 
dominated by the fast non-radiative decay of the excited states [5,6]. The current techniques 
for imaging of blood cells and vessels are mainly based on the absorption of hemoglobin, the 
major component of blood. For example, recently developed stimulated emission microscopy 
and excited state absorption took the advantage of large absorption coefficient of hemoglobin 
and permit label-free imaging of erythrocytes (red blood cells) with high sensitivity and 
resolution [6,7]. The pump–probe imaging methods require sophisticated excitation sources. 
The signals of stimulated emission or excited state absorption could be interfered by other 
chromophores of absorption spectra overlapping with hemoglobin. A subwavelength-
resolution photoacoustic microscopy for in vivo vasculature imaging was demonstrated very 
recently [8]. The technique is also based on the absorption of hemoglobin. 
It is well known that hemoglobin, like other metalloporphyrins, possesses two well 
separated absorption states, named as Q-band and Soret band (or B-band) as shown in Fig. 1, 
respectively [9]. Certain type of metalloporphyrins can emit fluorescence from both states 
centered normally at 650 nm and 430 nm, respectively [10], owing to the large energy 
separation between them. In particular, the unique high energy emission from the Soret band 
can become detectable when it is not quenched by inter- and intra-molecular interactions [11]. 
Indeed, we discovered for the first time that hemoglobin emits blue TPEF signal when it is 
excited by the visible femtosecond laser light. In this work, we first characterize the TPEF 
signals measured from the hemoglobin solutions in time and wavelength domains. Then we 
verify that the fluorescence signals emitted from the erythrocytes originate from the 
hemoglobin and demonstrate that hemoglobin fluorescence can provide good contrast to 
image the erythrocytes. In principle, this implementation could be easily incorporated into a 
standard mainstream two-photon excitation microscopy  for noninvasive imaging of 
erythrocytes and microvasculature in vivo. 
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Fig. 1. The electronic energy level diagram of hemoglobin (The Soret or B- and Q-bands are 
due to transitions between the a(π) and eg(π) orbitals). 
2. Methods and Materials 
2.1 Instrumentation of time-resolved spectroscopic imaging system 
A time-resolved spectroscopic imaging system (Fig. 2) was instrumented for the study of two 
photon excited Soret fluorescence of hemoglobin [12,13]. The excitation sources in the 
wavelength range of 600-750 nm were from a tunable femtosecond Ti:sapphire laser and the 
ultrafast supercontinuum generation in a photonic crystal fiber. A long pass filter (HQ680LP, 
Chroma) was placed at the exit of the femtosecond laser to remove the superfluorescence 
from the laser. The supercontinuum was generated from a photonic crystal fiber (PCF, NL-
1.4-775, Crystal Fiber). The femtosecond Ti:sapphire laser (Mira 900, Coherent) of 
wavelength tuned at 745 nm was used as the pump source [14]. The supercontinuum beam in 
visible band was purified by an interference band-pass filters at 600 ± 20 nm (D600/40M, 
Chroma) or 650 ± 22 nm (HQ650/45X, Chroma) to produce the femtosecond excitations of 
wavelength below 700 nm. In the study of hemoglobin fluorescence excited at the wavelength 
over 700 nm, the tunable laser light was used as the excitation source directly. The full width 
at half maximum (FWHM) of the autocorrelation curves for the supercontinuum at 600 nm 
and 650 nm and the Ti:sapphire laser light measured by an autocorrelator (Pulsecheck-50, 
APE GmbH, Germany) were about 800 fs, 600 fs and 250 fs, respectively. The excitation 
power of each beam was less than 15 mW on the sample. A water immersion objective (40 × , 
1.15 NA, Olympus) was used to focus the excitation beam(s) into the examined samples and 
collect the backscattered TPEF signals. A sampling area, typically 50 × 50 um or 100 × 100 
um, was created by scanning a pair of x-y galvo mirrors. The objective lens was driven by an 
actuator to achieve the depth scanning. A dichroic mirror (FF510, Semrock) was placed above 
the objective to reflect the TPEF signals to the detection system and a short-pass filter (SP01-
532RU or FF01-680/SP, Semrock) was used to reject the reflected excitation light. The TPEF 
signals were relayed by a telescope to a fiber bundle that conducted the TPEF signals to a 
spectrograph. For the spectroscopic measurements of hemoglobin solutions, a cooled CCD 
(NTE/CCD-1340/400-EMB, Roper Scientific, Trenton, New Jersey) was used to record high-
resolution TPEF spectra in the range from 400 to 530 nm. For the TPEF lifetime measurement 
and spectroscopic imaging, the CCD detector was replaced with a linear array of 
photomultiplier tubes (PMT) connected with a time-correlated single photon counting 
(TCSPC) module (PML-16-C-0 and SPC-150, Becker & Hickl). The system recorded time-
resolved fluorescence signals in 16 consecutive spectral bands from 300 to 500 nm at 13 nm 
interval and provided the capability to simultaneously detect TPEF signal in time and 
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of about 0.4 and 1.5 um, respectively. The spectrum and image acquisition time was set to 8 
seconds. 
 
Fig. 2. Schematic diagram of the spectroscopic imaging system. BS: beam splitter; M: mirror; 
BP: band-pass filter; DM: dichroic mirror; SP: short-pass filter; FB: fiber bundle; M-TCSPC: 
time-correlated single photon counting (TCSPC) module equipped with a multichannel PMT 
array. 
2.2 Chemical solution preparation 
The stabilized human lyophilized ferrous hemoglobin powder (H0267) was purchased from 
Sigma-Aldrich for the preparation of hemoglobin solutions. According to the product 
information, the highly purified hemoglobin powder was obtained via standard 
chromatographic separation method. However, the powders consist of certain amount of ferric 
hemoglobin (<15%) that were produced during the processes of purification and packaging 
(see description of Sigma-Aldrich hemoglobin products at http://www.sigmaaldrich.com/life-
science/biochemicals/biochemical-products.html?TablePage=16192492). This indicated that 
the signal measured from the solutions made of Sigma hemoglobin powder would be a 
mixture of ferrous and ferric hemoglobin. To study the interference from the ferric 
hemoglobin (methemoglobin), we prepared the solutions for the TPEF spectroscopy 
measurements using the pure methemoglobin powder (M5882) purchased from Sigma-
Aldrich. 
It is well known that the native hemoglobin in blood is dominated by ferrous hemoglobin 
[15]. The measurement of the TPEF signal from the ferrous hemoglobin solution is desirable 
for this study. In order to reduce the oxidization of hemoglobin and avoid the interference of 
methemoglobin, we extracted the hemoglobin from fresh blood sample following a simple 
standard procedure [16]. Because of the existence of the methemoglobin reductase in the fresh 
blood [15], it is expected that the home-extracted hemoglobin sample is dominated by ferrous 
hemoglobin. In the extraction of hemoglobin, the blood cells in the blood sample freshly 
withdrawn from mice were packed by spinning at 3000 rpm for 3 minutes and then washed 
with phosphate buffered saline (PBS) to remove the plasma. This procedure was repeated for 
a few times to ensure that the plasma was completely removed. Then one unit volume of 
blood cells was thoroughly mixed with one unit volume of deionized water and 0.4 volume of 
toluene. The mixture was stored at 4°C for at least 24 hours to ensure complete hemolysis. 
The solution was then spun at 13000 rpm for 10 minutes and the layer of clear hemoglobin 
solution was aspirated by using a syringe. This solution was then filtered by using a syringe 
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large molecules. The filtered hemoglobin solution was stored at 4°C for future use. We found 
that the absorption spectrum of extracted hemoglobin was identical to the oxyhemoglobin. 
The hemoglobin concentration in the solution was then determined by the oxyhemoglobin 
absorption spectrum with a commercial absorption spectrometry (Ultrospec 4300 pro 
UV/Visible Spectrophotometer, GE Healthcare, UK) [17,18]. 
In this work, we studied the TPEF characteristics of the solutions made of Sigma 
hemoglobin, Sigma methemoglobin and home-extracted hemoglobin of concentrations about 
15g/L, 20g/L and 50g/L, respectively. The solutions were held in a cuvette with a microscope 
coverslip as the TPEF measurement window. To prevent the possible strong hemoglobin re-
absorption to the TPEF signal, we kept the focal point of excitation at about 5 μm below the 
coverslip to make sure that the measured sample was optically thin. We found that the re-
absorption to the fluorescence was negligible because the TPEF spectral characteristics 
remained unchanged by further diluting the hemoglobin samples. To study the TPEF signals 
from oxygenated and deoxygenated blood, the oxyhemoglobin was prepared by saturation of 
the hemoglobin solution with the oxygen gas, and the deoxyhemoglobin was derived by 
adding sodium dithionite to the hemoglobin solution. The absorption spectra of 
oxyhemoglobin and deoxyhemoglobin solutions were measured by using a commercial 
absorption spectrometry to precisely determine the oxygen saturation in the oxyhemoglobin 
and deoxyhemoglobin solutions, respectively [19]. 
2.3 Estimation of relative two-photon excitation efficiency 
For femtosecond laser with wavelength λex, pulse repetition rate fP, pulse width τP, and average 
power Pave, the collectable TPEF intensity is given by following relationship [20,21]: 
 
2 2 2
2
() ave
f
P P ex
P NA
I
f hc
κπδ η
τλ

= 

   (1) 
where κ and NA are a factor taking into account the collection efficiency and the numerical 
aperture of the microscope system, respectively. h and c are the Planck’s constant and speed 
of light, respectively. Therefore, for the measurements of a sample with the same imaging 
setup, the relative excitation efficiency of the TPEF signal at different excitation wavelengths, 
2() ex ηλ , can be estimated as: 
 
2
2 2 ()
f P ex
ex
ave
I
P
τλ
ηλ ε =    (2) 
where ε is a proportional constant, while If, τP and Pave are three measurables. In this study, If 
is the fluorescence signal detected by the cooled CCD. The pulse width τP and the averaged 
excitation power Pave of supercontinuum and laser at different wavelengths were measured 
using an autocorrelator (Pulsecheck-50, APE GmbH, Germany) and a power meter (Model 
2832-C Dual-channel power meter, Newport, USA), respectively. It should be pointed out that 
since the excitation light at 600 and 650 nm are filtered out from the supercontinuum. Their 
pulse shapes are different from the nearly transform limited Gaussian pulse of the Ti:Sapphire 
femtosecond laser. This may cause certain error in the comparison of the excitation efficiency 
of supercontinuum pulses at 600 nm and 650 nm with the laser pulses of wavelength over 700 
nm. 
3. Results and discussions 
3.1 TPEF characteristics of the chemical solutions 
We measured the TPEF spectra of Sigma hemoglobin solution excited by the femtosecond 
light of wavelength range from 600 to 750 nm. As shown in Fig. 3(a), although the spectral 
peaks of hemoglobin remain around 440 nm at different excitation wavelengths, the shoulder 
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indicated  previously, the hemoglobin powder from Sigma-Aldrich contains ~15% 
methemoglobin. The measured TPEF spectra must be the mixture of hemoglobin and 
methemoglobin signals. To study whether the signal of methemoglobin, the major interference 
composition in the hemoglobin powder, could distort the TPEF spectral characteristics of 
hemoglobin, we measured the TPEF fluorescence spectra from the pure methemoglobin 
solution. The TPEF spectra of methemoglobin excited at different wavelengths are shown in 
Fig. 3(b). As can be seen, the spectral lineshapes of methemoglobin are completely different 
from those measured from Sigma hemoglobin solution as shown in Fig. 3(a). Furthermore, we 
calculated the excitation efficiency of TPEF signals from Sigma hemoglobin and 
methemoglobin. The results are presented in Fig. 3(c). We found that the fluorescence 
excitation efficiency of Sigma hemoglobin decreases rapidly with the increase of excitation 
wavelength, while the excitation efficiency of methemoglobin fluorescence does not change 
significantly. Therefore, the TPEF signals of Sigma hemoglobin excited at 600 nm should be 
dominated by the fluorescence of ferrous hemoglobin because of its higher excitation 
efficiency and concentration. However, the contribution of methemoglobin signal becomes 
significant at longer excitation wavelength. In addition, we studied the temporal 
characteristics of TPEF signals from the Sigma hemoglobin and methemoglobin solutions. 
The representative results excited at 600 nm are shown in Fig. 3(d). We found that the time-
resolved fluorescence signals from both solutions are almost identical to the system response 
about 230 ps (FWHM), indicating the extremely short fluorescence lifetime. This may be due 
to the extremely short excited state lifetime of Soret band because of its strongly allowed 
transition and competition with fast intersystem crossing. 
 
Fig. 3. TPEF characteristics of Sigma hemoglobin and methemoglobin. (a) TPEF spectra of 
hemoglobin (Sigma-Aldrich, H0267) excited at the wavelengths from 600 to 750 nm; (b) TPEF 
spectra of methemoglobin (Sigma-Aldrich, M5882); (c) Excitation efficiency of hemoglobin 
and methemoglogin as a function of excitation wavelength; (d) Time-resolved hemoglobin and 
methemoglobin two-photon fluorescence excited at 600 nm. 
Next, we measured TPEF signals from the solution made of the home-extracted 
hemoglobin. In order to verify whether the home-extracted hemoglobin is dominated by 
ferrous hemoglobin, we compared the 600 nm excited TPEF spectrum acquired from home-
extracted hemoglobin solution with that measured from Sigma hemoglobin solution. The 
results are shown in Fig. 4(a). As can be seen, two spectra mainly overlap with each other 
except at short and long wavelength edges. The inconsistency at edges may be contributed 
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spectra provides evidence that the ferrous hemoglobin is dominant in the home-extracted 
sample. Because the hemoglobin signal measured from the home-extracted solution would be 
less distorted by methemoglogin, we used the home-extracted solution to characterize the 
hemoglobin TEPF signals in the following study. 
We measured the TPEF signals from home-extracted hemoglobin solutions excited by the 
femtosceond pulse light  of wavelength range from 600 to 750 nm. Detailed TPEF 
characteristics are shown in Fig. 4(b-e). The fluorescence emission peak is located at about 
438 nm when the excitation light is in the range from 600 nm to 750 nm as shown in Fig. 4(b). 
This is consistent with the Soret fluorescence emission wavelength of other metalloporphyins 
reported previously [10]. We noticed that a constant background appeared in all the TPEF 
spectra measured from the hemoglobin solutions and the erythrocyte sample in following 
experiments. However, its origin has not been identified yet. The Soret band should have a 
very short lifetime because of its strongly allowed transition and competition with fast 
intersystem crossing. Again, this is partially confirmed by our measured fluorescence intensity 
decay shown in Fig. 4(c), which is almost identical to the system response about 230 ps 
(FWHM). As can be seen from Fig. 4(d), the hemoglobin fluorescence is effectively excited 
when the excitation wavelength is below 700 nm, which is simply due to the near resonance 
with the Q-band as indicated in the energy level diagram in Fig. 1. The fluorescence signal 
becomes very weak when the excitation wavelength is over 750 nm. This may explain why 
tow-photon excited hemoglobin fluorescence was not observed previously. The measured 
fluorescence intensity shows a quadratic dependency on the excitation power as presented in 
the inset figure of Fig. 4(d), proving that the observed Soret fluorescence of hemoglobin is a 
result of two-photon excitation process. The fluorescence spectrum of oxyhemoglobin and 
deoxyhemoglobin are shown in Fig. 4(e). It is found that there are no significant difference in 
spectral characteristics between oxyhemoglobin and deoxyhemoglobin. 
Furthermore, we measured the oxidation dependent TPEF signals to further verify that the 
measured two-photon fluorescence signal was indeed from ferrous hemoglobin. It is known 
that the oxidation of ferrous hemoglobin turns the iron atom from divalent to trivalent, 
resulting in ferric hemoglobin, named methemoglobin. A standard procedure was followed to 
oxidize the hemoglobin solution [22]. The TPEF spectra of the solution before and after 
oxidation by adding hydrogen peroxide are presented in Fig. 4(f), in which the spectrum of 
pure methemoglobin purchased from Sigma-Aldrich is presented for a comparison. It can be 
clearly seen that the oxidized hemoglobin has produced almost identical spectrum as the pure 
methemoglobin. With all these evidences, we can firmly conclude that the origin of the 
observed fluorescence emission peaked at 438 nm is indeed hemoglobin. 
Finally, we compared the two-photon excitation cross-section of hemoglobin with that of 
tryptophan at 600 nm excitation because the two-photon excitation cross-section of tryptophan 
has  been studied [23]. In addition, the tryptophan fluorescence has been demonstrated to 
produce high contrast images from living animal model in vivo [13,24]. It could be used to 
predict whether the hemoglobin fluorescence is detectable at tissue level. In this study, the 
tryptophan (T0254, Sigma) was dissolved at the concentration of 5 mM in deionized water. 
The concentration of the hemoglobin solution was precisely measured by a standard method 
based on the absorption spectra [17,18]. All solutions were adjusted to about pH 7.0. We 
measured the TPEF signals from the hemoglobin and tryptophan solutions under the same 
excitation condition. The detection system was the 16-channel PMT array with response 
calibration from 300 to 500 nm, covering the TPEF signals of tryptophan and hemoglobin. 
The comparison results show that the two-photon excitation cross-section of hemoglobin is 
about a factor of 3 higher than that of tryptophan. 
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Fig. 4. Spectral and temporal TPEF characteristics of home-extracted hemoglobin. (a) TEPF 
spectrum of Sigma and home-extracted hemoglobin excited at 600 nm; (b) TPEF spectra of 
home-extracted hemoglobin excited at different wavelengths; (c) Time decay curve of the 
fluorescence excited at 600 nm; (d) Excitation efficiency as a function of excitation 
wavelength. Inset: dependency of fluorescence signal on excitation power; (e) TPEF spectra of 
oxy-  and deoxy-hemoglobin excited at 600 nm and 700 nm; (f) TPEF spectra of 
methemoglobin and hemoglobin before and after oxidation by using hydrogen peroxide. 
3.2 TPEF images and characteristics of erythrocytes 
Hemoglobin is the dominant component in erythrocytes (red blood cells) that constitute about 
45% of whole blood by volume, while the plasma constitute about 54.3% and leukocytes 
(white blood cells) about only 0.7% [25]. Here, we explored the potential of imaging 
erythrocytes based on the intrinsic hemoglobin fluorescence. We focused on the hemoglobin 
fluorescence excited at 600 nm because of its high excitation efficiency. Moreover, the 
spectral and temporal characteristics of TPEF signals from blood cells were recorded by the 
time-resolved spectroscopic imaging system that analyzed the signals in both time and 
wavelength domains [12,13]. A TPEF image of the erythrocytes sample freshly extracted 
from mice blood is shown in Fig. 5(a), from which the individual doughnut-shaped 
erythrocytes are clearly visualized. The image was formed using the TPEF signal in the 
wavelength band of 420-460 nm, covering the peak of hemoglobin Soret fluorescence. To 
analyze the characteristics of the fluorescence from erythrocytes, we integrated the signals 
recorded at all pixels of erythrocytes to produce the TPEF spectrum and time-decay of 
erythrocytes fluorescence, respectively. As shown in Fig. 5(b), the spectral and temporal 
characteristics of erythrocytes TPEF signals are almost the same as those measured from 
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image of erythrocytes were indeed originated from hemoglobin in the cells. 
 
Fig. 5. Image and fluorescence characteristics of erythrocytes at 600 nm excitation. (a) TPEF 
image of erythrocytes in PBS solution (The sampling area of the image: 50 × 50 um); (b) TPEF 
spectrum and time decay curve of erythrocytes. 
4. Conclusion 
In summary, we discovered Soret fluorescence emission from hemoglobin via two-photon 
excitation. The spectral and lifetime characteristics of the hemoglobin and methemoglobin 
fluorescence have been studied by using a time-resolved spectroscopic imaging system. The 
hemoglobin fluorescence provides sharp contrast to image individual erythrocyte. Because of 
the relatively large two-photon excitation cross-section of hemoglobin, the TPEF fluorescence 
could be used for label-free imaging the microvasculature from heterogeneous tissue 
constituents based on its unique spectral and temporal characteristics of hemoglobin 
fluorescence. 
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